These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 19359367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.
    Mitchell VA, Jeong HJ, Drew GM, Vaughan CW.
    Neuropsychopharmacology; 2011 Aug; 36(9):1801-10. PubMed ID: 21525858
    [Abstract] [Full Text] [Related]

  • 3. Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling.
    Drew GM, Mitchell VA, Vaughan CW.
    J Neurosci; 2008 Jan 23; 28(4):808-15. PubMed ID: 18216189
    [Abstract] [Full Text] [Related]

  • 4. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.
    Aubrey KR, Drew GM, Jeong HJ, Lau BK, Vaughan CW.
    J Physiol; 2017 Jan 01; 595(1):165-178. PubMed ID: 27461371
    [Abstract] [Full Text] [Related]

  • 5. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
    Sheinin A, Talani G, Davis MI, Lovinger DM.
    J Neurophysiol; 2008 Aug 01; 100(2):1041-52. PubMed ID: 18497350
    [Abstract] [Full Text] [Related]

  • 6. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.
    Liao HT, Lee HJ, Ho YC, Chiou LC.
    Br J Pharmacol; 2011 May 01; 163(2):330-45. PubMed ID: 21232043
    [Abstract] [Full Text] [Related]

  • 7. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.
    Drew GM, Lau BK, Vaughan CW.
    J Neurosci; 2009 Jun 03; 29(22):7220-9. PubMed ID: 19494144
    [Abstract] [Full Text] [Related]

  • 8. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray.
    Lau BK, Vaughan CW.
    Mol Pharmacol; 2008 Nov 03; 74(5):1392-8. PubMed ID: 18678620
    [Abstract] [Full Text] [Related]

  • 9. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
    Vaughan CW, Connor M, Bagley EE, Christie MJ.
    Mol Pharmacol; 2000 Feb 03; 57(2):288-95. PubMed ID: 10648638
    [Abstract] [Full Text] [Related]

  • 10. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
    Wilson-Poe AR, Lau BK, Vaughan CW.
    Br J Pharmacol; 2015 Jan 03; 172(2):681-90. PubMed ID: 24916363
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
    Ho YC, Lee HJ, Tung LW, Liao YY, Fu SY, Teng SF, Liao HT, Mackie K, Chiou LC.
    J Neurosci; 2011 Oct 12; 31(41):14600-10. PubMed ID: 21994376
    [Abstract] [Full Text] [Related]

  • 13. Labetalol facilitates GABAergic transmission to rat periaqueductal gray neurons via antagonizing beta1-adrenergic receptors--a possible mechanism underlying labetalol-induced analgesia.
    Xiao C, Zhou C, Atlas G, Delphin E, Ye JH.
    Brain Res; 2008 Mar 10; 1198():34-43. PubMed ID: 18262504
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
    Kawahara H, Drew GM, Christie MJ, Vaughan CW.
    Br J Pharmacol; 2011 Jul 10; 163(6):1214-22. PubMed ID: 21175570
    [Abstract] [Full Text] [Related]

  • 15. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
    Gregg LC, Jung KM, Spradley JM, Nyilas R, Suplita RL, Zimmer A, Watanabe M, Mackie K, Katona I, Piomelli D, Hohmann AG.
    J Neurosci; 2012 Jul 11; 32(28):9457-68. PubMed ID: 22787031
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
    Inada H, Maejima T, Nakahata Y, Yamaguchi J, Nabekura J, Ishibashi H.
    Neuroscience; 2010 Feb 17; 165(4):1377-89. PubMed ID: 19961906
    [Abstract] [Full Text] [Related]

  • 20. Retrograde release of endocannabinoids inhibits presynaptic GABA release to second-order baroreceptive neurons in NTS.
    Chen CY, Bonham AC, Dean C, Hopp FA, Hillard CJ, Seagard JL.
    Auton Neurosci; 2010 Dec 08; 158(1-2):44-50. PubMed ID: 20580326
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.